Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia
-
- Tohru Minamino
- Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
-
- Helen Christou
- Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
-
- Chung-Ming Hsieh
- Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
-
- Yuxiang Liu
- Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
-
- Vijender Dhawan
- Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
-
- Nader G. Abraham
- Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
-
- Mark A. Perrella
- Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
-
- S. Alex Mitsialis
- Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
-
- Stella Kourembanas
- Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
書誌事項
- 公開日
- 2001-07-10
- DOI
-
- 10.1073/pnas.161272598
- 公開者
- Proceedings of the National Academy of Sciences
この論文をさがす
説明
<jats:p>Chronic hypoxia causes pulmonary hypertension with smooth muscle cell proliferation and matrix deposition in the wall of the pulmonary arterioles. We demonstrate here that hypoxia also induces a pronounced inflammation in the lung before the structural changes of the vessel wall. The proinflammatory action of hypoxia is mediated by the induction of distinct cytokines and chemokines and is independent of tumor necrosis factor-α signaling. We have previously proposed a crucial role for heme oxygenase-1 (HO-1) in protecting cardiomyocytes from hypoxic stress, and potent anti-inflammatory properties of HO-1 have been reported in models of tissue injury. We thus established transgenic mice that constitutively express HO-1 in the lung and exposed them to chronic hypoxia. HO-1 transgenic mice were protected from the development of both pulmonary inflammation as well as hypertension and vessel wall hypertrophy induced by hypoxia. Significantly, the hypoxic induction of proinflammatory cytokines and chemokines was suppressed in HO-1 transgenic mice. Our findings suggest an important protective function of enzymatic products of HO-1 activity as inhibitors of hypoxia-induced vasoconstrictive and proinflammatory pathways.</jats:p>
収録刊行物
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 98 (15), 8798-8803, 2001-07-10
Proceedings of the National Academy of Sciences
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1361981469080642560
-
- ISSN
- 10916490
- 00278424
- https://id.crossref.org/issn/07644450
-
- データソース種別
-
- Crossref